Reducing environmental pollution and tackling quality issues to stave off resistance
The challenges created by antimicrobial resistance are only set to grow. Join us to equip yourself with the most up-to-date facts and knowledge
A world without antibiotics would be a terrifying place
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
Involving the public in research tackling superbugs
Cancers and bacteria develop resistance to drugs in remarkably similar ways
The first TB drug approved in 40 years gave hope to sufferers of drug resistant tuberculosis and ushered in a new class of antibiotics
Source: © Shutterstock
Technique that creates a comprehensive catalogue of mutations in antibiotic’s target reveals how drugs might be improved
Peptoids disrupt enveloped viruses’ lipid membranes as well as targeting fungi and bacteria
Series 3 of the Royal Society of Chemistry’s ‘Brought to you by chemistry’ podcast covers antimicrobial resistance over six episodes. Host Alex Lathbridge talks to guests including Alison Holmes (president of the International Society for Infectious Diseases), Kaamini Walia (India Council for Medical Research), Sally Davies (former UK Chief Medical Officer) – and ITV’s favourite GP, Hilary Jones.
Molecular-scale ‘Jurassic Park’ process could uncover new medicines
Funds will support upgrades to laboratories and staff training
Palaeogenomic approach allows natural product researchers to ‘go back in time’
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
Understanding of formation of deadly supramolecular structures could help build improved antimicrobials
Bacteria aren’t able to develop resistance against nanomotor’s deadly action
Prospecting in bacterial genomes offers hope in search for new antimicrobial drugs
Decoupling payment from prescriptions helps preserve last-line antibiotics and encourage R&D
Largest study of its kind creates map of drug contamination hotspots
Why do some medicines stop working, and can we avoid it for Covid-19 antivirals?